Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Current Treatment Options in Cardiovascular Medicine|March 21, 2018
Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and TreatmentJohan Spetz, Javid Moslehi, Kristopher SarosiekCancer Biotherapy & Radiopharmaceuticals|June 25, 2013
Biodistribution and dosimetry of free 211At, 125I- and 131I- in ratsJohan Spetz, Nils Rudqvist, Eva Forssell-AronssonNeuroendocrinology|May 11, 2012
Radionuclide therapy via SSTR: future aspects from experimental animal studiesEva Forssell-Aronsson, Johan Spetz, Håkan AhlmanInternational Review of Cell and Molecular Biology|January 13, 2019
T Cells and Regulated Cell Death: Kill or Be KilledJohan Spetz, Adam G Presser, Kristopher A SarosiekPlos One|July 13, 2018
Deconvolution of expression microarray data reveals 131I-induced responses otherwise undetected in thyroid tissueBritta Langen, Nils Rudqvist, Johan Spetz, et al.Cell Death & Disease|January 8, 2026
Platelet aging and desialylation increase apoptotic priming and BCL-XL dependenceRenata Grozovsky, Cameron S Fraser, Xingping Qin, et al.Scientific Reports|October 26, 2016
Non-targeted transcriptomic effects upon thyroid irradiation: similarity between in-field and out-of-field responses varies with tissue typeBritta Langen, Nils Rudqvist, Johan Spetz, et al.NMR in Biomedicine|January 30, 2019
Multiparametric MR for non-invasive evaluation of tumour tissue histological characteristics after radionuclide therapyMikael Montelius, Oscar Jalnefjord, Johan Spetz, et al.Translational Oncology|January 15, 2018
Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine TumorMikael Montelius, Johan Spetz, Oscar Jalnefjord, et al.Oncology Reports|October 14, 2011
Biodistribution of 177Lu-octreotate and 111In-minigastrin in female nude mice transplanted with human medullary thyroid carcinoma GOT2Johanna Dalmo, Nils Rudqvist, Johan Spetz, et al.Pageof 4